SCHEMBL22038469

SCHEMBL22038469

CC1(C)c2cccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc(-c5ccccc5)c4)n3)c2-c2ccc3ccccc3c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.35
MAPT P10636 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TSHR P16473 2/20 0.35
MAPK1 P28482 2/20 0.35
HSD17B10 Q99714 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
KDM4E B2RXH2 1/20 0.35
TP53 P04637 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PDE7A Q13946 2/20 0.33
PDE7B Q9NP56 2/20 0.33
CA12 O43570 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23743372 0.99 TSHR (0.36) SMN1; SMN2MAPTL3MBTL1TSHRMAPK1
SCHEMBL23743379 0.96 AURKA (0.35) SMN1; SMN2MAPTL3MBTL1TSHRMAPK1
SCHEMBL23743289 0.95 MAPT (0.38) SMN1; SMN2MAPTL3MBTL1TSHRMAPK1
SCHEMBL22037685 0.95 MAPT (0.37) SMN1; SMN2MAPTTSHRMAPK1HSD17B10
SCHEMBL23743298 0.94 ALDH1A1 (0.35) SMN1; SMN2MAPTL3MBTL1TSHRMAPK1
SCHEMBL24778314 0.94 ALDH1A1 (0.35) SMN1; SMN2MAPTL3MBTL1TSHRMAPK1
SCHEMBL23743378 0.93 MAPT (0.38) SMN1; SMN2MAPTL3MBTL1TSHRMAPK1
SCHEMBL19885857 0.93 TSHR (0.36) SMN1; SMN2MAPTL3MBTL1TSHRMAPK1
SCHEMBL23743275 0.93 MAPT (0.40) SMN1; SMN2MAPTL3MBTL1TSHRMAPK1
SCHEMBL22037916 0.92 CYP11B1 (0.40) SMN1; SMN2MAPTTSHRALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200168805-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200168805-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ELOVL1, ELOVL6, ELOVL5 SMN1; SMN2 995/4885MAPT 883/4885L3MBTL1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.